{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T16:56:11Z","timestamp":1763225771773},"reference-count":75,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.4065\/75.11.1161","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:17:28Z","timestamp":1232759848000},"page":"1161-1168","source":"Crossref","is-referenced-by-count":33,"title":["Antimicrobial Resistance in Streptococcus pneumoniae: Implications for Patients With Community-Acquired Pneumonia"],"prefix":"10.4065","volume":"75","author":[{"given":"Carol E.","family":"Chenoweth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Saint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Joseph P.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Mark","family":"Fendrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/75.11.1161_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2007-1021315","article-title":"The cost of treating patients with community-acquired pneumonia","volume":"20","author":"Lave","year":"1999","journal-title":"Semin Respir Crit Care Med"},{"key":"10.4065\/75.11.1161_bib2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archinte.1997.00440360129015","article-title":"Community-Based Pneumonia Incidence Study Group. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio","volume":"157","author":"Marston","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.4065\/75.11.1161_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00005792-199707000-00007","article-title":"Invasive pneumococcal infections: a comparison between adults and children","volume":"76","author":"Rahav","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.4065\/75.11.1161_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0002-9343(99)00050-9","article-title":"Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? a microbiologie study of lung aspirates in consecutive patients with community-acquired pneumonia","volume":"106","author":"Ruiz-Gonzalez","year":"1999","journal-title":"Am J Med"},{"key":"10.4065\/75.11.1161_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199508243330803","article-title":"The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta","volume":"333","author":"Hofmann","year":"1995","journal-title":"N Engl J Med"},{"key":"10.4065\/75.11.1161_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1086\/514538","article-title":"Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994","volume":"25","author":"Hibbs","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1378\/chest.110.6.1499","article-title":"Oral empiric treatment of community-acquired pneumonia: a multicenter, double-blind, randomized study comparing sparfloxacin with roxilhromycin","volume":"110","author":"Ortqvist","year":"1996","journal-title":"Chest"},{"key":"10.4065\/75.11.1161_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"key":"10.4065\/75.11.1161_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00063198-199703000-00013","article-title":"Antimicrobial resistance: implications for managing respiratory failure","volume":"3","author":"Chenoweth","year":"1997","journal-title":"Curr Opin Pulm Med"},{"key":"10.4065\/75.11.1161_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/514953","article-title":"Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program","volume":"27","author":"Doern","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM199611073351907","article-title":"Antimicrobial-drug resistance","volume":"335","author":"Gold","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4065\/75.11.1161_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0732-8893(98)00108-4","article-title":"Epidemiologie trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds","volume":"33","author":"Jones","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.4065\/75.11.1161_bib13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/clinids\/20.5.1195","article-title":"Infections caused by erythromycin-resistanl Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study","volume":"20","author":"Moreno","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib14","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1086\/513628","article-title":"Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study","volume":"24","author":"Clavo Sanchez","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00006454-199610000-00030","article-title":"Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae","volume":"15","author":"Appelbaum","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl B","key":"10.4065\/75.11.1161_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/43.suppl_2.1","article-title":"A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new \u201crespiratory quino-lones,\u201d","volume":"43","author":"Blondeau","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"suppl C","key":"10.4065\/75.11.1161_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/43.suppl_3.37","article-title":"Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections","volume":"43","author":"Casellas","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"suppl C","key":"10.4065\/75.11.1161_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jac\/43.suppl_3.15","article-title":"In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance","volume":"43","author":"Thomson","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/75.11.1161_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4065\/75.11.1161_bib20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/21202","article-title":"Emergence of vancomycin tolerance in Streptococcus pneumoniae","volume":"399","author":"Novak","year":"1999","journal-title":"Nature"},{"key":"10.4065\/75.11.1161_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/315216","article-title":"Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis","volume":"181","author":"McCullers","year":"2000","journal-title":"J Infect Dis"},{"key":"10.4065\/75.11.1161_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1164\/ajrccm.160.1.9806048","article-title":"Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia","volume":"160","author":"Sanyal","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.4065\/75.11.1161_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1378\/chest.114.1.115","article-title":"A prospective, multicenler study of a pneumonia practice guideline","volume":"114","author":"Rhew","year":"1998","journal-title":"Chesi"},{"key":"10.4065\/75.11.1161_bib24","doi-asserted-by":"crossref","first-page":"8I1","DOI":"10.1086\/513953","article-title":"Community-acquired pneumonia in adults: guidelines for management","volume":"26","author":"Bartlett","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib25","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm\/148.5.1418","article-title":"American Thoracic Society, Medical Section of the American Lung Association. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy","volume":"148","author":"Niederman","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.4065\/75.11.1161_bib26","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1016\/S0002-9343(99)00102-3","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in North America","volume":"107(A)","author":"Barry","year":"1999","journal-title":"Am J Med"},{"issue":"1A","key":"10.4065\/75.11.1161_bib27","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1016\/S0002-9343(99)00107-2","article-title":"New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae","volume":"107","author":"Tomasz","year":"1999","journal-title":"Am J Med"},{"issue":"suppl 2","key":"10.4065\/75.11.1161_bib28","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1086\/513854","article-title":"Penicillin-binding protein-mediated resistance in pneumococci and staphylococci","volume":"179","author":"Chambers","year":"1999","journal-title":"J Infect Dis"},{"key":"10.4065\/75.11.1161_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3201\/eid0506.990603","article-title":"Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98","volume":"5","author":"Doern","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.4065\/75.11.1161_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/15.1.77","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: an overview","volume":"15","author":"Appelbaum","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/514937","article-title":"Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States","volume":"27","author":"Docrn","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM198707023170104","article-title":"Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci","volume":"317","author":"Pallares","year":"1987","journal-title":"N Engl J Med"},{"issue":"1A","key":"10.4065\/75.11.1161_bib33","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/S0002-9343(99)00101-1","article-title":"Pneumococcal disease in Sweden: experiences and current situation","volume":"107","author":"Ortqvist","year":"1999","journal-title":"Am J Med"},{"key":"10.4065\/75.11.1161_bib34","first-page":"656","article-title":"Geographic variation in penicillin resistance in Streptococcus pneumoniae-selected sites. United States, 1997","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.4065\/75.11.1161_bib35","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/infdis\/163.6.1273","article-title":"Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987","volume":"163","author":"Spika","year":"1991","journal-title":"J Infect Dis"},{"key":"10.4065\/75.11.1161_bib36","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/AAC.34.11.2075","article-title":"Antimicrobial resistance among respiratory isolates of Haemophlius influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States","volume":"34","author":"Jorgensen","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.11.1161_bib37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.1994.03510470035031","article-title":"Emergence of drug-resistant pneumococcal infections in the United States","volume":"271","author":"Breiman","year":"1994","journal-title":"JAMA"},{"key":"10.4065\/75.11.1161_bib38","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/AAC.38.10.2419","article-title":"In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from US medical centers in 1992 and 1993","volume":"38","author":"Barry","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.11.1161_bib39","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/174.5.986","article-title":"The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System","volume":"174","author":"Butler","year":"1996","journal-title":"J Infect Dis"},{"key":"10.4065\/75.11.1161_bib40","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.40.5.1208","article-title":"Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study","volume":"40","author":"Doern","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.11.1161_bib41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0149-2918(98)80113-6","article-title":"In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance","volume":"20","author":"Thornsberry","year":"1998","journal-title":"Clin Ther"},{"key":"10.4065\/75.11.1161_bib42","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199806253382601","article-title":"An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents","volume":"338","author":"Nuorti","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/75.11.1161_bib43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s100960050239","article-title":"Increase in penicillin resistance rates in Belgium due to clonal spread of a penicillin-resistant 23F Streptococcus pneumoniae strain","volume":"18","author":"Hoefnagels-Schuermans","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/75.11.1161_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1542\/peds.103.2.409","article-title":"Streptococcus pneumoniae Working Group Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae","volume":"103","author":"Decks","year":"1999","journal-title":"Pedicatries"},{"key":"10.4065\/75.11.1161_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/514526","article-title":"Resistance patterns of Streptococcus pneumoniae from carriers attending daycare centers in southwestern Greece","volume":"25","author":"Syrogiannopoulos","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/clinids\/22.1.63","article-title":"Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey","volume":"22","author":"Bedos","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib47","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/clinids\/19.5.884","article-title":"Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study","volume":"19","author":"Nava","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib48","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1128\/AAC.39.10.2282","article-title":"Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States","volume":"39","author":"McDougal","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.11.1161_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0732-8893(98)00037-6","article-title":"Bacterial resistance: a worldwide problem","volume":"31","author":"Jones","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.4065\/75.11.1161_bib50","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CMR.11.4.628","article-title":"Management of infections due to antibiotic-resistant Streptococcus pneumoniae","volume":"11","author":"Kaplan","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.4065\/75.11.1161_bib51","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s100960050337","article-title":"Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens","volume":"18","author":"Cizman","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4065\/75.11.1161_bib52","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/00006454-199610000-00031","article-title":"Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media","volume":"15","author":"Jacobs","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/75.11.1161_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.41.1.129","article-title":"Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods","volume":"41","author":"Fasola","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.11.1161_bib54","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/archinte.159.3.266","article-title":"Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia","volume":"159","author":"Ailani","year":"1999","journal-title":"Arch intern Med"},{"issue":"suppl 2","key":"10.4065\/75.11.1161_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-199958002-00006","article-title":"Pharmacokinetics and pharmacodynamics of fluoro-quinolones","volume":"58","author":"Turnidge","year":"1999","journal-title":"Drugs"},{"key":"10.4065\/75.11.1161_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0732-8893(96)00068-5","article-title":"Levoflox-acin in vitro activity against bacteremic isolates of Streptococcus pneumoniae","volume":"25","author":"Plouffe","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.4065\/75.11.1161_bib57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.43.2.357","article-title":"Spanish Surveillance Group for Respiratory Padtogens. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a I-year (1996-1997) multicenter surveillance study","volume":"43","author":"Baquero","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.11.1161_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1592\/phco.20.4.245.34880","article-title":"Moxifloxacin, a new antibiotic designed to treat community-acquired respiratory tract infections: a review of microbiologic and pharmacokinetic-pharmacodynamic characteristics","volume":"20","author":"Nightingale","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.4065\/75.11.1161_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/AAC.41.1.101","article-title":"In vitro activity of BAY 12-8039, a new fluoroquinolone","volume":"41","author":"Woodcock","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.11.1161_bib60","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF01691157","article-title":"Activity of trovafloxacin against blood isolates of Streptococcus pneumoniae in Sweden","volume":"15","author":"Liljequist","year":"1996","journal-title":"EurJ Clin Microbio) Infect Dis"},{"key":"10.4065\/75.11.1161_bib61","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/520286","article-title":"Drug-resistant Streptococcus pneu moniae","volume":"26","author":"Campbell","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.4065\/75.11.1161_bib62","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.1996.03530270034028","article-title":"Bactercmia with Streptococcus pneumoniae: implications for therapy and prevention","volume":"275","author":"Plouffe","year":"1996","journal-title":"JAMA"},{"key":"10.4065\/75.11.1161_bib63","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.4065\/75.11.1161_bib64","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1164\/ajrccm.159.6.9808049","article-title":"Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae","volume":"159","author":"Ewig","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.4065\/75.11.1161_bib65","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.4065\/75.11.1161_bib66","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0924-8579(98)00097-1","article-title":"Antibiotic resistance and therapeutic options in lower respiratory tract infections","volume":"11","author":"Bouza","year":"1999","journal-title":"Im J Antimicrob Agents"},{"key":"10.4065\/75.11.1161_bib67","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1378\/chest.116.2.535","article-title":"The significance of serum vs tissue levels of antibiotics in the treatment of penicillin-resistant Streptococcus pneumoniae and community-acquired pneumonia: are we looking in the wrong place?","volume":"116","author":"Siegel","year":"1999","journal-title":"Chest"},{"key":"10.4065\/75.11.1161_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1378\/chest.116.1.115","article-title":"A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections","volume":"116","author":"Amsden","year":"1999","journal-title":"Chest"},{"key":"10.4065\/75.11.1161_bib69","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archinte.159.9.970","article-title":"Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study","volume":"159","author":"Fine","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.4065\/75.11.1161_bib70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9343(97)00274-X","article-title":"Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia","volume":"104","author":"Gilbert","year":"1998","journal-title":"Am J Med"},{"key":"10.4065\/75.11.1161_bib71","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch Inlern Med"},{"key":"10.4065\/75.11.1161_bib72","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1128\/AAC.40.8.1950","article-title":"Comparative activities of clariehromycin, crythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci","volume":"40","author":"Edniel","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.11.1161_bib73","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.41.9.1965","article-title":"A multicenter, randomized study comparing the efficacy and safety of intravenous and\/or oral levofloxacin versus ceftriaxone and\/or cefuroximc axctil in treatment nf adults with community-acquired pneumonia","volume":"41","author":"File","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/75.11.1161_bib74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0732-8893(97)00234-4","article-title":"Antimicrobial activity and spectrum investigation of eight broad-spectrum \u03b2-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States","volume":"30","author":"Jones","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.4065\/75.11.1161_bib75","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00003495-200059040-00007","article-title":"Linezolid","volume":"59","author":"Clemett","year":"2000","journal-title":"Drugs"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611649732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611649732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T13:56:06Z","timestamp":1558101366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611649732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S0025619611649732"],"URL":"https:\/\/doi.org\/10.4065\/75.11.1161","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}